Table 4.

Incidence of solicited local injection site reactions after the first andsecond vaccination.

	Adjuvanted HAI-05						Unadjuvanted HAI-05		Placebo
	15 µg N = 18		45 µg N = 20		90 µg N = 20		90 µg N = 20		N = 22
Vaccination n (%) a	Dose 1 b	Dose 2 c	Dose 1	Dose 2	Dose 1	Dose 2	Dose 1	Dose 2	Dose 1	Dose 2
Pain at Injection Site	11 (61.1)	10 (55.6)	12 (60.0)	11 (55.0)	16 (80.0)	10 (50.0)	1 (5.0)	3 (15.0)	3 (13.6)	1 (4.5)
Redness	0	0	0	0	0	0	0	0	0	0
Swelling	0	1 (5.6)	0	0	2 (10.0)	1 (5.0)	0	0	0	0

^a: Number (%) of subjects reporting symptom. Each subject was counted only once.

^b: Between Days 1 and 8.

^c: Between Days 22 and 29.